Healthcare & Medical Devices Global On demand · 24-48h

Global Virtual Second Opinion Service Market Strategic Research Report

Global Virtual Second Opinion Service Market Strategic Resea…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Virtual Second Opinion Service Market
$6.13B2025
9.5%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: General Medical Second Opinion, Cancer Second Opinion, Mental Health Second Opinion, Genetic Second Opinion, Others

By Application: Adult, Children, Elderly

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Amwell, Cedars-Sinai, SecondOpinionExpert, Inc., Medicaim, Cleveland Clinic, DISC, MEDCONSonline, 2nd.MD, Second Opinion International, WorldCare, PayerFusion, Proactive MD, PinnacleCare, Included Health, Penn Medicine

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 112 pages
Market size 2025
$6.13B
Billion USD
Forecast CAGR
9.5%
2025-2032
Forecast 2032
$11.6B
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

نظرة عامة

Scope of the Report

The global Virtual Second Opinion Service market size is predicted to grow from US$ 6,135 million in 2025 to US$ 11,480 million in 2032; it is expected to grow at a CAGR of 9.5% from 2026 to 2032.

A Virtual Second Opinion Service is a healthcare service that allows patients to seek a second opinion from medical experts remotely, without the need for an in-person visit. It involves sharing medical records, test results, and other relevant information with the experts through an online platform. The experts then review the case and provide their opinion, diagnosis, or treatment recommendations. This service is particularly useful for patients who want to confirm a diagnosis, explore alternative treatment options, or gain more confidence in their healthcare decisions. It can be accessed from anywhere, making it convenient for patients who may not have access to specialized medical expertise locally.

The virtual second opinion service market is experiencing significant growth due to several factors. One of the major trends in this market is the increasing adoption of telemedicine and virtual healthcare services. The COVID-19 pandemic has accelerated the adoption of virtual healthcare solutions, including second opinion services, as people seek remote medical consultations to avoid physical contact and reduce the risk of infection.The market concentration in the virtual second opinion service market is relatively low, with several players competing for market share. However, there are a few key players that dominate the market. These players have established partnerships with renowned medical institutions and have a strong network of specialists, which gives them a competitive advantage. In terms of sales regions, North America is currently the largest market for virtual second opinion services. The region has a well-developed healthcare infrastructure, high internet penetration, and a large population that is willing to pay for virtual healthcare services. Europe is also a significant market for virtual second opinion services, driven by the increasing adoption of telemedicine and the presence of advanced healthcare systems. Overall, the virtual second opinion service market is experiencing rapid growth, driven by the increasing adoption of telemedicine, rising demand for specialized medical expertise, and the need for remote healthcare solutions. The market concentration is relatively low, with several players competing for market share, but a few key players dominate the market. North America is currently the largest market, followed by Europe, while Asia Pacific is expected to witness significant growth in the coming years.

This report presents a comprehensive overview of the global Virtual Second Opinion Service market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • General Medical Second Opinion
  • Cancer Second Opinion
  • Mental Health Second Opinion
  • Genetic Second Opinion
  • Others

Segment by Delivery Mode (User Experience & Workflow)

  • Asynchronous (document review+written opinion)
  • Synchronous (video/telephone consultation)
  • Hybrid (async review+synchronous follow-up)

Segment by Service Scope (Geography & Jurisdiction)

  • Domestic (same country/region)
  • Cross-border (international expert panel)
  • Regional (local hub-based)

Segment by Application

  • Adult
  • Children
  • Elderly

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Virtual Second Opinion Service market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Adult, Children, Elderly evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Virtual Second Opinion Service Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 9.5%
Regional growth momentum
Market share by segment
Key metrics
Base value
$6.13B
2025
Forecast
$11.6B
2032
CAGR
9.5%
2025–2032
Regions
5
global
Key companies
AmwellCedars-SinaiSecondOpinionExpert, Inc.MedicaimCleveland ClinicDISCMEDCONSonline2nd.MD
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
General Medical Second OpinionCancer Second OpinionMental Health Second OpinionGenetic Second OpinionOthers
By Application
AdultChildrenElderly

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 General Medical Second Opinion
  • 3.1.3 Cancer Second Opinion
  • 3.1.4 Mental Health Second Opinion
  • 3.1.5 Genetic Second Opinion
  • 3.1.6 Others
  • 3.1.7 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Adult
  • 4.1.3 Children
  • 4.1.4 Elderly
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Amwell
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Cedars-Sinai
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 SecondOpinionExpert, Inc.
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Medicaim
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Cleveland Clinic
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 DISC
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 MEDCONSonline
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 2nd.MD
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Second Opinion International
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 WorldCare
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 PayerFusion
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Proactive MD
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 PinnacleCare
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Included Health
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Penn Medicine
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Virtual Second Opinion Service market?
The global Virtual Second Opinion Service market is estimated at US$ 6.13 billion in 2025 (base year) and is projected to reach US$ 11.48 billion by 2032.
What is the forecast CAGR for the Virtual Second Opinion Service market?
The market is expected to grow at a CAGR of 9.5% from 2026 to 2032, expanding from US$ 6.13 billion in 2025 to US$ 11.48 billion in 2032, roughly 1.9 times its base-year value.
What is Virtual Second Opinion Service?
A Virtual Second Opinion Service is a healthcare service that allows patients to seek a second opinion from medical experts remotely, without the need for an in-person visit. It involves sharing medical records, test results, and other relevant information with the experts through an online platform. The experts then review the case and provide their opinion, diagnosis, or treatment recommendations.
What are the main segments of the Virtual Second Opinion Service market by type?
By type, the market is segmented into General Medical Second Opinion, Cancer Second Opinion, Mental Health Second Opinion, Genetic Second Opinion and Others.
Which applications drive demand in the Virtual Second Opinion Service market?
Key applications covered include Adult, Children and Elderly.
Who are the key players in the Virtual Second Opinion Service market?
Key players profiled include Amwell, Cedars-Sinai, SecondOpinionExpert, Medicaim, Cleveland Clinic, DISC, MEDCONSonline and 2nd.MD, among 15 companies covered in total.
Which regions and countries are covered for Virtual Second Opinion Service?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Virtual Second Opinion Service market?
Europe is also a significant market for virtual second opinion services, driven by the increasing adoption of telemedicine and the presence of advanced healthcare systems.
Who should buy the Virtual Second Opinion Service market report?
The report is intended for manufacturers and solution providers, distributors and end users in Adult, Children and Elderly, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Virtual Second Opinion Service market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from ‏3,500.00 US$
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.